Allergan Recalls One Lot of Viokace Tablets Due to Stability Testing Failures
Allergan is recalling one lot of Viokace tablets because stability testing results did not meet specifications for enzyme profile.
- Product
- Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine, CA 92612, Manufactured in Canada, NDC 58914-117-10
- Category
- Drug
- Distribution
- Distributed nationwide